首页 >
法规速递
-
Page: Data Analysis and Real World Interrogation Network (DARWIN EU)-2026/3/4
2026-03-05查看详情 > -
Document: Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 March 2026-2026/4/1
2026-04-02查看详情 > -
国家药监局关于修订倍他司汀制剂说明书的公告（2023年第72号）-2023/6/13
2023-06-14查看详情 > -
关于公开征求ICH《Q5A（R2）：来源于人或动物细胞系生物技术产品的病毒安全性评价》实施建议和中文版意见的通知-2023/12/12
2023-12-21查看详情 > -
Page: Accelerating Clinical Trials in the EU (ACT EU)-2025/1/22
2025-01-23查看详情 > -
Document: New Approach Methodologies EU-IN Horizon Scanning Report-2025/2/24
2025-02-25查看详情 > -
Document: IRIS guide to registration and RPIs-2025/4/1
2025-04-02查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第九十二批）的通告（2025年第20号）-2025/5/13
2025-05-14查看详情 > -
Page: How we work-2025/6/19
2025-06-20查看详情 > -
Document: Guidelines on good pharmacovigilance practices (GVP): Introductory cover note, last updated with new Addendum II to Module VI on masking of personal data in individual case safety reports submitted to EudraVigilance-2025/7/24
2025-07-25查看详情 >
